Kwon, C. H. Et Al. 2020. Clinically confirmed DEL-1 as a myokine attenuates lipid-induced inflammation and insulin resistance in 3T3-L1 adipocytes via AMPK/HO-1- pathway. Adipocyte , vol.9, no.1 , 576-586.

Kwon, C. H., Sun, J. L., Kim, M. J., Abd El-Aty, A. M., Jeong, J. H., & Jung, T. W., (2020). Clinically confirmed DEL-1 as a myokine attenuates lipid-induced inflammation and insulin resistance in 3T3-L1 adipocytes via AMPK/HO-1- pathway. Adipocyte , vol.9, no.1, 576-586.

Kwon, Chang Et Al. "Clinically confirmed DEL-1 as a myokine attenuates lipid-induced inflammation and insulin resistance in 3T3-L1 adipocytes via AMPK/HO-1- pathway," Adipocyte , vol.9, no.1, 576-586, 2020

Kwon, Chang H. Et Al. "Clinically confirmed DEL-1 as a myokine attenuates lipid-induced inflammation and insulin resistance in 3T3-L1 adipocytes via AMPK/HO-1- pathway." Adipocyte , vol.9, no.1, pp.576-586, 2020

Kwon, C. H. Et Al. (2020) . "Clinically confirmed DEL-1 as a myokine attenuates lipid-induced inflammation and insulin resistance in 3T3-L1 adipocytes via AMPK/HO-1- pathway." Adipocyte , vol.9, no.1, pp.576-586.

@article{article, author={Chang Hyuk Kwon Et Al. }, title={Clinically confirmed DEL-1 as a myokine attenuates lipid-induced inflammation and insulin resistance in 3T3-L1 adipocytes via AMPK/HO-1- pathway}, journal={Adipocyte}, year=2020, pages={576-586} }